• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Introduction to 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate (CAS No. 61363-29-9)

8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate, chemically designated as CAS No. 61363-29-9, is a significant compound in the field of biochemical research and pharmaceutical development. This cyclic nucleotide derivative has garnered considerable attention due to its unique structural properties and potential biological activities. As a modified form of cyclic adenosine monophosphate (cAMP), it exhibits distinct interactions with cellular signaling pathways, making it a valuable tool in studying molecular mechanisms and drug discovery.

The compound belongs to the class of cyclic nucleotides, which are ubiquitous second messengers in cells. Cyclic nucleotides, including cAMP and its derivatives, play pivotal roles in regulating a wide array of physiological processes such as metabolism, muscle contraction, neurotransmission, and gene expression. The introduction of aminoethyl groups into the adenosine backbone in 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate introduces novel functional properties that can influence its binding affinity and stability compared to native cAMP.

Recent advancements in biochemical research have highlighted the importance of cyclic nucleotides in therapeutic applications. 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate has been studied for its potential role in modulating enzyme activity and cellular responses. For instance, its ability to interact with protein kinase A (PKA) and other cAMP-dependent protein kinases has been explored in detail. This interaction is crucial for understanding how cellular processes are regulated in response to external stimuli.

One of the most compelling aspects of 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate is its stability under physiological conditions. Unlike native cAMP, which is rapidly degraded by phosphodiesterases, this derivative exhibits enhanced resistance to enzymatic hydrolysis. This increased stability makes it a more effective tool for studying long-term signaling pathways and developing novel therapeutic strategies.

The synthesis of 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate involves complex chemical methodologies that require precise control over reaction conditions. The introduction of the aminoethyl group at the 8-position of adenosine necessitates careful selection of protecting groups and coupling reagents to ensure high yield and purity. Advances in synthetic chemistry have made it possible to produce this compound on a larger scale, facilitating further research and development.

In the realm of drug discovery, 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate has been investigated as a potential lead compound for treating various diseases. Its unique structural features suggest that it may interact with target proteins differently from native cAMP, offering new opportunities for therapeutic intervention. For example, studies have shown that this compound may have neuroprotective effects by modulating neurotransmitter release and reducing oxidative stress.

The pharmacological properties of 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate have also been explored in preclinical models. Research indicates that it may enhance cognitive function by influencing cholinergic signaling pathways. Additionally, its potential role in regulating inflammation and immune responses has been studied, suggesting applications in treating chronic inflammatory diseases.

From a computational biology perspective, molecular modeling studies have provided insights into the binding interactions of 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate with its target proteins. These studies have helped identify key residues involved in binding and have guided the design of more potent derivatives. The integration of experimental data with computational methods has accelerated the discovery process and improved our understanding of the compound's mechanism of action.

The future prospects for 8-(2-Aminoethyl)aminoadenosine 3',5'-cyclic monophosphate are promising, with ongoing research focusing on optimizing its pharmacokinetic properties and exploring new therapeutic applications. As our understanding of cellular signaling pathways continues to grow, compounds like this will play an increasingly important role in developing targeted therapies for complex diseases.

• 39824-30-1(Adenosine,8-[(6-aminohexyl)amino]-, cyclic 3',5'-(hydrogen phosphate))
• 53602-90-7(Adenosine 5'-(tetrahydrogen triphosphate), 8-[(6-aminohexyl)amino]-)
• 56878-15-0(5'-Adenylic acid, 8-[(3-aminopropyl)amino]-)
• 56878-16-1(5'-Adenylic acid, 8-[(3-amino-2-hydroxypropyl)amino]-)
• 56878-14-9(5'-Adenylic acid, 8-[(2-aminoethyl)amino]-)
• 33823-18-6(Adenosine,8-(methylamino)-, cyclic 3',5'-(hydrogen phosphate))
• 33823-17-5(Adenosine,8-[(2-hydroxyethyl)amino]-, cyclic 3',5'-(hydrogen phosphate) (9CI))
• 30685-40-6(Adenosine, 8-amino-,cyclic 3',5'-(hydrogen phosphate) (9CI))
• 31357-06-9(8-PIP-cAMP)
• 214276-80-9(Adenosine,2-[(6-aminohexyl)amino]-, cyclic 3',5'-(hydrogen phosphate))